Accession Number : ADA292505
Title : Flying Waivers for History of Angioplasty and Myocardial Infraction.
Descriptive Note : Technical memo.,
Corporate Author : ARMSTRONG LAB BROOKS AFB TX AEROSPACE MEDICINE DIRECTORATE
Personal Author(s) : Pickard, Jeb S. ; Burton, Joe E.
PDF Url : ADA292505
Report Date : 18 NOV 1994
Pagination or Media Count : 4
Abstract : Angioplasty has become common for the treatment of significant coronary disease (SCAD). In many cases an aeromedically significant lesion (50% or greater stenosis) may be dilated to less than 50%, raising the question of whether these patients could be considered under minimal coronary artery disease (MCAD) criteria, and allowed to fly. Suitability of MCAD to fly is based on a study of ACS patients with 20-40% lesions, who had a annual cardiac event rate of 0.6%. An extensive literature review by AOC presented at ASMA in May 1994 showed that the lowest cardiac event rate, after one year following successful angioplasty, was 2.4% per year with no subsequent decline. A lesion classified as SCAD which is subsequently dilated to less than 50% cannot be considered to be equivalent to MCAD. The Aeromedical Consult Service recommends that aviators who require angioplasty be permanently disqualified from all classes of flying duties.
Descriptors : *STRESS(PHYSIOLOGY), *DIAGNOSIS(MEDICINE), *MYOCARDIAL INFARCTION, LITERATURE SURVEYS, PILOTS, CLINICAL MEDICINE, HISTORY, SURGERY, CORONARY DISEASE, AEROMEDICAL EVACUATION, CORONARY ARTERIES, STENOSIS.
Subject Categories : Medicine and Medical Research
Distribution Statement : APPROVED FOR PUBLIC RELEASE